Walleye Trading LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$324,225
-52.4%
13,100
-45.6%
0.00%
-50.0%
Q3 2022$681,000
-41.2%
24,078
-39.5%
0.00%
-50.0%
Q1 2022$1,159,000
+105.5%
39,822
+132.1%
0.00%
+100.0%
Q4 2021$564,000
-13.4%
17,155
+21.7%
0.00%0.0%
Q3 2021$651,000
+133.3%
14,100
+119.1%
0.00%
+100.0%
Q4 2020$279,000
-90.8%
6,435
-88.6%
0.00%
-94.7%
Q2 2020$3,027,000
-32.2%
56,600
-55.0%
0.02%
-44.1%
Q1 2020$4,466,000
-24.5%
125,895
+1.6%
0.03%
-15.0%
Q4 2019$5,916,000
+237.3%
123,900
+128.8%
0.04%
+166.7%
Q3 2019$1,754,000
-26.1%
54,147
+13.8%
0.02%
-28.6%
Q2 2019$2,374,000
+0.6%
47,600
+36.1%
0.02%
+16.7%
Q1 2019$2,359,000
-23.8%
34,972
-47.9%
0.02%
-21.7%
Q4 2018$3,094,000
+57.9%
67,102
+164.1%
0.02%
+130.0%
Q3 2018$1,959,000
+190.7%
25,403
+217.5%
0.01%
+150.0%
Q2 2018$674,000
+13380.0%
8,000
+7900.0%
0.00%
Q2 2017$5,0001000.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders